Sort by
Refine Your Search
-
Employer
-
Field
-
Status: Open Applications open: 23/06/2025 Applications accepted at any time View printable version [.pdf] About this scholarship Description/Applicant information This PhD scholarship supports a student passionate about developing novel therapeutics for brain diseases such as stroke and...
-
learning by using Bayesian learning principles. Among other things, Bayesian learning gives AI systems the ability to quantitatively express a degree of belief about a prediction or statement. By bridging
-
therapeutic targets. The scholarship provides opportunities to apply statistical genetics approaches to dementia research within a collaborative and supportive research environment. Student type Future Students
-
Opportunity to help develop a novel nanophotonic therapy targeting drug-resistant hypertension Full-time, fixed term (3.5 years) position at our Hawthorn campus Annual stipend $40,000 About the Role
-
Opportunity to help develop a novel nanophotonic therapy targeting drug-resistant hypertension Full-time, fixed term (3.5 years) position at our Hawthorn campus Annual stipend $40,000 About the Role
-
, communities and homes to prevent problem behaviour and mental ill-health. It is expected the project will lead to the development of systemic and targeted interventions to improve local and global health
-
atypical ILI duration and the extent to which these vary over time and among different populations, identify demographic groups likely to benefit most from interventions targeting ILI prevention and care
-
insights into the mental health impacts of physical violence among women, this research will inform targeted interventions that can reduce the strain on mental health services and improve societal well-being
-
pre-clinical studies for its ability to prevent tumour growth by targeting the Sonic Hedgehog (HH) receptor, which is a different mechanism than its antifungal action. Itraconazole affects the crucial
-
benefits for patients and health care services. Aims To investigate the outcomes of a pharmacist-led antimicrobial stewardship (AMS) program that targets UTI management in Western Australian RACHs